Francis Medical Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Francis Medical's estimated annual revenue is currently $12M per year.(i)
  • Francis Medical's estimated revenue per employee is $251,000

Employee Data

  • Francis Medical has 48 Employees.(i)
  • Francis Medical grew their employee count by 4% last year.

Francis Medical's People

NameTitleEmail/Phone
1
Founder/Director/President/CTOReveal Email/Phone
2
VP, Clinical AffairsReveal Email/Phone
3
VP FinanceReveal Email/Phone
4
VP Research, Development, and OperationsReveal Email/Phone
5
Director Regulatory and Quality AssuranceReveal Email/Phone
6
President, CEO & DirectorReveal Email/Phone
7
Director MarketingReveal Email/Phone
8
Principal Clinical Research ManagerReveal Email/Phone
9
Supply Chain and Mfg Operations ManagerReveal Email/Phone
10
Principal Quality Engineering ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$30.6M1224%N/AN/A
#2
$18.6M7435%N/AN/A
#3
$75.6M30120%N/AN/A
#4
$12M484%N/AN/A
#5
$2.8M1110%N/AN/A
#6
$3M120%N/AN/A
#7
$24.6M985%N/AN/A
#8
$11.5M4621%N/AN/A
#9
$7.3M294%N/AN/A
#10
$13.8M55-10%N/AN/A
Add Company

What Is Francis Medical?

Francis Medical is dedicated to providing a solution to cure endourological cancers. Francis Medical is focused on creating a minimally invasive treatment solutions for prostate, kidney, and bladder cancer through the use of convective thermal water vapor. Currently, the company is in clinical trials for tissue ablation of the prostate. Founded in 2018, Francis Medical is located in Maple Grove, Minnesota. Francis Medical, Inc. formerly named NxPhase Medical, Inc. is a company that was created after Boston Scientific (BSC) acquired NxThera, Inc. in April of 2018. As a part of the BSC/NxThera transaction, a separate and independent entity, NxPHASE Medical, Inc. (“NxPHASE”), was established, and shares of NxPHASE were distributed to the shareholders of BSC/NxThera. In addition, BSC/NxThera granted NxPHASE a license to utilize BSC/NxThera's convective vapor ablation technology to develop, evaluate and commercialize certain devices to treat prostate, kidney and bladder cancer (“NxPHASE Field of Use”), while BSC/NxThera remains focused on the treatment of benign prostatic hyperplasia. Late in 2018, NxPhase Medical, Inc. went through a rebranding process and selected Francis Medical, Inc. as it's new brand and identity. The name and foundation of the company is a tribute to and legacy for Michael Hoey's (founder/inventor) father Francis Hoey whose life was ended by prostate cancer with treatments that had harsh implications on his normal daily living. In December 2018, Francis Medical completed an $18.0 million round of Series A financing.

keywords:N/A

N/A

Total Funding

48

Number of Employees

$12M

Revenue (est)

4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Francis Medical News

2022-04-20 - Pope cancels agenda on medical advice because of knee pain ABC News

Pope cancels agenda on medical advice because of knee pain ABC News

2022-04-19 - Off-duty South Gate police detective killed in Norwalk traffic crash Press Telegram

Off-duty South Gate police detective killed in Norwalk traffic crash Press Telegram

2022-03-22 - Credible threat' leads to enhanced security at St. Francis Hospital in ... WTVM

Credible threat' leads to enhanced security at St. Francis Hospital in ... WTVM

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$13.6M48-8%N/A
#2
$35M487%N/A
#3
$6.5M509%N/A
#4
$12.6M52-4%N/A
#5
$7.2M536%N/A